ALNY
Alnylam Pharmaceuticals Inc
219.90$
+0.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.23 | -2.25 | -3.59 | -4.23 | -5.59 | -2.55 | -5.35 | -5.42 | -4.45 | 0.83 | -0.07 | 3.89 | |
| 0.16 | 0.23 | 0.18 | 0.15 | 0.06 | 0.50 | 0.65 | 0.76 | 0.70 | 0.78 | 0.44 | 0.41 | |
| 0.45 | 0.55 | 0.88 | 1.03 | 1.57 | 1.60 | 1.22 | 1.40 | 1.90 | 1.77 | 2.13 | 2.59 | |
| -0.09 | 0.56 | 0.84 | 1.08 | 1.85 | 1.85 | 1.36 | 1.89 | 2.53 | – | – | – | |
| -0.40 | 0.42 | 0.20 | -0.03 | 0.45 | 3.68 | -0.11 | -1.37 | -0.29 | 0.09 | -1.68 | -3.30 | |
| 0.12 | 0.15 | 0.75 | 1.15 | 1.26 | 1.28 | 0.61 | 0.64 | 0.59 | 0.50 | 0.27 | 0.44 | |
| -7.39 | -3.83 | 1.67 | -3.21 | 2.71 | -3.82 | -3.79 | -2.31 | 1.39 | -2.69 | -0.92 | 3.24 | |
| 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | |
| -0.22 | 0.00 | -0.01 | 0.00 | -0.03 | 7.81 | 2.61 | 2.08 | 2.13 | – | – | – | |
| 2.02 | 1.79 | 1.75 | -1.33 | -0.30 | -0.27 | 1.74 | 4.22 | 2.09 | 0.00 | 0.00 | -4.04 | |
| 9.91 | 7.34 | 2.08 | 12.42 | 0.65 | 7.53 | 8.65 | 10.53 | 3.50 | 1.38 | 2.30 | -2.27 | |
| 0.30 | 1.26 | 0.15 | 4.99 | -2.23 | 1.16 | -0.44 | 2.73 | 0.38 | -0.43 | 1.20 | 5.12 | |
| -2.35 | -2.41 | -4.35 | -5.38 | -6.85 | -3.83 | -5.96 | -6.06 | -5.04 | 0.34 | -0.33 | 3.46 |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.